Study Summary
This trial will study how well a mobile app (Roadmap 2.0) and Fitbit help caregivers of cancer patients. The goal is to see if using the app is feasible and acceptable.
Eligible Conditions
- Quality of Life
- Cancer
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 1 Secondary · Reporting Duration: At time of enrollment
At time of enrollment
Enrollment rate
Day 120
Roadmap 2.0 login rate
Survey completion rate
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Roadmap 2.0 + Fitbit Charge 3
1 of 1
Experimental Treatment
100 Total Participants · 1 Treatment Group
Primary Treatment: Roadmap 2.0 information system · No Placebo Group · N/A
Roadmap 2.0 + Fitbit Charge 3Experimental Group · 3 Interventions: Survey administration, Wearable activity sensor, Roadmap 2.0 information system · Intervention Types: Other, Other, Behavioral
Trial Logistics
Trial Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: at time of enrollment
Who is running the clinical trial?
University of Michigan Rogel Cancer CenterLead Sponsor
270 Previous Clinical Trials
18,055 Total Patients Enrolled
Sung Won Choi, MD, MSPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
4 Previous Clinical Trials
3,295 Total Patients Enrolled
Eligibility Criteria
Age Any Age · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: